We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
CG
1
Column Group
California
$47M
EC
2
EcoR1 Capital
California
$16.7M
BlackRock
3
BlackRock
New York
$12M +$1.88M +526,863 +13%
Vanguard Group
4
Vanguard Group
Pennsylvania
$7.23M -$3.16M -885,263 -24%
SG
5
StepStone Group
California
$4.07M
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$2.95M +$715K +200,409 +21%
Morgan Stanley
7
Morgan Stanley
New York
$2.33M +$149K +41,823 +5%
State Street
8
State Street
Massachusetts
$2.22M +$418K +117,214 +16%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$2.2M +$214K +60,119 +8%
Nuveen
10
Nuveen
North Carolina
$2.02M +$44.4K +12,453 +2%
EC
11
Euclidean Capital
New York
$1.93M
Federated Hermes
12
Federated Hermes
Pennsylvania
$1.52M +$1.47M +412,097 +238%
Jacobs Levy Equity Management
13
Jacobs Levy Equity Management
New Jersey
$1.5M -$586K -164,353 -22%
JP Morgan Chase
14
JP Morgan Chase
New York
$1.42M +$25K +7,015 +1%
BC
15
Boxer Capital
California
$1.29M
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$1.14M -$90.5K -25,365 -5%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$952K -$4.99K -1,400 -0.4%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$919K +$278K +77,816 +28%
Northern Trust
19
Northern Trust
Illinois
$914K -$3.47K -972 -0.3%
JRP
20
Jasper Ridge Partners
California
$902K
Citadel Advisors
21
Citadel Advisors
Florida
$897K +$960K +269,101 +348%
Two Sigma Investments
22
Two Sigma Investments
New York
$871K -$19.9K -5,588 -2%
GCP
23
GSA Capital Partners
United Kingdom
$831K -$387K -108,557 -25%
Charles Schwab
24
Charles Schwab
California
$704K -$191K -53,436 -16%
Renaissance Technologies
25
Renaissance Technologies
New York
$654K -$274K -76,900 -23%